Q1 Which of the following descriptions about HIV and TB interaction is right ? Which of the following descriptions about HIV and TB interaction is right.

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

HIV TB. World wide TB is the most common cause of death in people with HIV About 1/3 of HIV infected people worldwide are co-infected with TB (co-infection.
TB & HIV Infection: Treatment
TB & HIV Infection: Treatment Your name Institution/organization Meeting Date International Standard 8, 13 TB & HIV Infection: Treatment Your name Institution/organization.
TB and HIV Management Dr A.L. Pozniak Chelsea and Westminster Hospital London, UK.
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
TB and HIV: Tightly Linked… and Why We Should Care.
Recommendations of BU/HIV expert panel influenced by results from Akonolinga All BU patients should be offered quality provider-initiated HIV testing and.
Case management of TB With HIV/AIDS co-infection Chris Nelson, Public Health Nurse.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Launch of Revised Strategy of TB- HIV Cross Referrals Delhi State AIDS Control Society Govt. of Delhi By Dr A.K. Gupta MD (Pediatrics) Additional Project.
Introduction Hypothesis Conclusions Specific Aims In-home Intervention Improves Outcomes of Tuberculosis Patients in Zimbabwe, Africa Olga Kishek, Tess.
HIV and TB Co-infection North Dakota HIV Symposium May 19, 2010 David McNamara, M.D. Clinical Assistant Professor of Medicine University of North Dakota.
Immune Reconstitution Inflammatory Syndrome (IRIS)
In the name of God Fariba Rezaeetalab Assistant Professor.
TB and HIV Coinfection Bruce A. Bush, M.D.
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
HIV Early Treatment Project Groups 1 and 2 n Among HIV-infected participants in sub-Saharan Africa, does initiation of antiretroviral treatment (ART) at.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
A cost-effectiveness evaluation of preventive interventions for HIV-TB in Sub-Saharan Africa (Tanzania): Relevance for neurological infections Lucie Jean-Gilles.
Tuberculosis Surveillance and Disease Intersections in California
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
M ALNUTRITION. M ALNUTRITION AMONG IDU S : B ASIC FACTS Drug users are at increased risk of malnutrition regardless of whether or not they are infected.
TUBERCULOSIS IN THE AGE OF HIV Dr. Terry Baker Physician National Chest Hospital.
1 Bacille Calmette-Guerin Vaccine-Induced Disease in Children with HIV/AIDS HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
HIV related Opportunistic Diseases HIV related Opportunistic Diseases M.MEIDANI,MPH.MD.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Dr Kogie Naidoo Presented at the
Coordinator: Kézdi- Zaharia E. Iringó First author: Magyar Júlia Coauthor: Gyerő Réka.
Ukrainian TB mortality assessment 2008: Low HIV awareness and access to ART for TB patients associated with high HIV related TB mortality Presenting author:
TB/HIV management survey  Baseline audit in parallel with guidelines development process  Survey of clinician opinion and practice  Data collection.
The Timing of ART initiation in TB HIV co-infected patients: Impact on IRIS severity 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention 20.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
HIV/TB Integration in a Network of Voluntary Counseling/Testing Centers in HAITI Reynold Grand’Pierre MD, Marie Suze Jacquet MD, Jean W. Pape MD PEPFAR.
XDR-TB Presented by: :Mona Ahmed Sherif Supervised by: DR. SEHAM HAFEZ Supervised by: DR. SEHAM HAFEZ.
The immune reconstitution inflammatory syndrome (IRIS) in HIV infected patients comprises a group of inflammatory symptoms associated with the appearance.
HIV/AIDS By: Shawn Dye
Predictors of ART-associated TB in a prospective study: Results of the Kericho IRIS Study The Rainbow of IRIS in HIV Infection July 26, 2012 Fredrick.
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Immune Reconstitution Inflammatory Syndrome (IRIS)
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.
TB AND HIV/AIDS THE SITUATION AT BMC Care & Treatment Unit CME, 5/5/20166 PRESENTERS: Dr. Desideris Bernard, Dr. Magawa.
내과 R2 이지훈 N Engl J Med 2014;371:
Tuberculosis and HIV-AIDS: Achievements with ARV access Dr. Humberto Costa, MD Minister of Health, Brazil.
TB-H V Co-infection by Dr. Ker Hong Bee 11. LEARNING OBJECTIVES To know & understand about TB-HIV co- infection in relation to:- – interaction & prevalence.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
CURRENT CONCEPTS Tuberculosis N Engl J Med Feb 21;368(8): Alimuddin Zumla, M.D., Ph.D., Mario Raviglione, M.D., Richard Hafner, M.D., and.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Randomized clinical trial to determine efficacy and safety of antiretroviral therapy one week after tuberculosis therapy in patients with CD4 counts
Confronting HIV Associated TB in the era of increasing anti-TB drug resistance Chakaya J.M Kenya Medical Research Institute XVII International AIDS Conference,
Sarah Al-Obaydi M.B.Ch.B, MPH(c) Fulbright scholar.
Treatment Action Group TB/HIV Advocacy Toolkit August 2017
ART was initiated when indicated by WHO and national guidelines
Predictors of antiretroviral treatment associated tuberculosis in Ethiopia: a nested case control study Nebiyu Mesfin, MD.
Treatment Action Group TB/HIV Advocacy Toolkit NOVEMBER 2017
Dr Dawood Quiz questions.
TB-HIV Last updated: March 2018.
By: Dr Mirzaei.
Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study  S. Yan,
Figure 1 Associations between baseline cerebrospinal fluid
Future challenges for clinical care of an ageing population infected with HIV: a modelling study  Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,
When to START During an OI
Introduction to poster session and discussion
Crude Mortality Rate 2004 – 2017 (N=7845, 63% female)
Improving the Use of Medications to Treat Complex Health Problems in Resource-Poor Settings: Community-Based Examples from Haiti and Peru Jennifer Furin,
Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.
Presentation transcript:

Q1 Which of the following descriptions about HIV and TB interaction is right ? Which of the following descriptions about HIV and TB interaction is right ? A) HIV infection promotes the progression of primary TB infection A) HIV infection promotes the progression of primary TB infection B) HIV infection increases the risk of TB reactivation and re-infection B) HIV infection increases the risk of TB reactivation and re-infection C) The course of HIV infection is accelerated by TB infection C) The course of HIV infection is accelerated by TB infection D) All of the above D) All of the above

Q2 Which of the followings if wrong about the clinical presentation of tuberculosis in advanced HIV infection ? Which of the followings if wrong about the clinical presentation of tuberculosis in advanced HIV infection ? A) Cavitary lung lesions are frequently encountered A) Cavitary lung lesions are frequently encountered B) Higher proportion of extrapulmonary and disseminated TB infection B) Higher proportion of extrapulmonary and disseminated TB infection C) Higher incidence of Mycobacteraemia C) Higher incidence of Mycobacteraemia D) None of the above D) None of the above

Q3 The mortality of HIV-infected patients with TB is comparatively higher than that of HIV-negative. Followings are the risk factors of mortality among HIV-TB coinfected patients, except ~ The mortality of HIV-infected patients with TB is comparatively higher than that of HIV-negative. Followings are the risk factors of mortality among HIV-TB coinfected patients, except ~ A) Not receiving antiretroviral therapy (ART) A) Not receiving antiretroviral therapy (ART) B) MDR-TB B) MDR-TB C) Extra-pulmonary TB C) Extra-pulmonary TB D) Non-compliance D) Non-compliance E) None of the above E) None of the above

Q4 Which of the following statements is wrong about the co-administration of anti-TB and antiretroviral therapy (ART) ? Which of the following statements is wrong about the co-administration of anti-TB and antiretroviral therapy (ART) ? A) Treatment of TB always takes precedence over the treatment of HIV A) Treatment of TB always takes precedence over the treatment of HIV B) The immune reconstitution inflammatory syndrome (IRIS) has been reported up to one-third of patients B) The immune reconstitution inflammatory syndrome (IRIS) has been reported up to one-third of patients C) Deferring ART until completion of anti-TB treatment can avoid drug-drug interaction, high pills burden and IRIS without compromising the outcome C) Deferring ART until completion of anti-TB treatment can avoid drug-drug interaction, high pills burden and IRIS without compromising the outcome D) none of the above D) none of the above